Humon shares: the 2021 ESOP has not yet started to purchase the company's shares
Financial Associated Press, Dec. 6 (Xinhua) humon announced that as of the disclosure date of the announcement, the company's employee stock ownership plan in 2021 has not started to buy the company's shares. The company will timely perform the obligation of information disclosure in strict accordance with relevant regulations according to the implementation progress of the employee stock ownership plan in 2021.
This text is a result of machine translation.
Related companies：
Briefing Mar 21, 2025 05:14 PM
· Technology
Shanghai to Launch Its First Direct Passenger Flight Route to a Central Asian Country in May
In-depth
Technology
China’s E-bike Brands Going Global: A Review of 26 Leading Players
With the global e-bike market continuing to expand, Chinese e-bike companies are gradually shifting from being a manufacturing powerhouse to becoming a meaningful force in global competition. This article reviews a group of Chinese e-bike players and examines their overseas positioning and market entry paths—looking at how Chinese brands are securing a foothold in the next wave of globalization.
Dec 19, 2025 02:56 PM
Jan 30, 2026 06:00 PM
Jan 30, 2024 07:59 PM
Dec 11, 2023 08:49 PM
Jan 05, 2023 07:33 PM
Briefing Nov 26, 2021 11:38 AM
· Healthcare
Ganli pharmaceutical won the bid for centralized procurement of insulin glargine injection
Consumer Staples
CHAGEE to Enter the South Korean Market, First Store to Open in Q2
Mar 10, 2026 05:20 PM
Briefing Nov 26, 2021 11:30 AM
Special national collection of insulin: Ganli pharmaceutical Ganjing and asparagus insulin all reported the lowest prices: 48.71 yuan and 19.98 yuan
Briefing Nov 17, 2021 06:49 PM
Robin Li: Baidu has become the world's largest automated driving service provider.
Technology
Pacini Completes RMB 1 Billion+ Series B Financing
Recently, PaXini Tech (帕西尼感知科技), a global leader in embodied perception-driven general intelligence, announced that it has completed a Series B financing round exceeding RMB 1 billion, bringing the company’s valuation to over RMB 10 billion.
Mar 09, 2026 02:37 PM
Briefing Aug 20, 2021 05:48 PM
· Healthcare
During the 14th Five Year Plan period, China will restore 230 million mu of degraded grassland
Briefing Jul 23, 2021 10:13 AM
· Healthcare
Pharmaceutical and biological stocks fell sharply in early trading
See more
Read next
Insight
In-depth
Automotive · Analysis
Thinking of ASEAN as a single market is the biggest miscalculation for Chinese companies
Feb 19, 2026 12:00 PM
Insight
In-depth
Consumer Staples, Industrials, Communication
You're Invited: China's Innovation, Up Close
Feb 10, 2026 04:21 PM
Insight
In-depth
Automotive · Analysis
CES 2026 in Numbers | From Shenzhen to Las Vegas: Huaqiangbei’s Year-End Report
Jan 15, 2026 09:42 PM